Skip to content

Allele labels: risk/effect/reference/ancestral/major/wild-type perspectives

Definition

These labels answer different questions in GWAS files and papers: effect/non-effect/other define the statistical coding direction; risk/non-risk describe interpretation of direction for a phenotype; reference/alternative describe genome-assembly allele identity; ancestral/derived describe evolutionary state; major/minor describe frequency rank in a dataset; and wild-type/mutant are functional or experimental convention labels. They are related but not interchangeable.

How they differ

Effect allele Non-effect allele Other allele Risk allele Non-risk allele Reference allele Alternative allele Ancestral allele Derived allele Major allele Minor allele Wild-type allele Mutant allele
Primary role Statistical direction anchor for beta/log(OR). Counterpart to effect allele in biallelic reporting. Schema synonym for non-effect in some datasets. Interpretation label: increases risk in stated model. Opposite interpretation label to risk allele. Assembly-defined allele (REF) in reference genome build. Non-reference allele (ALT) relative to build. Inferred allele state in common ancestor. Mutated state relative to ancestral allele. More frequent allele in the analyzed dataset. Less frequent allele in the analyzed dataset. Conventionally "standard" allele in a functional/experimental context. Sequence-changed allele relative to a defined wild-type context.
Where mostly used Summary statistics, meta-analysis, PRS/MR harmonization. Summary statistics and harmonization workflows. File formats/column schemas (EA/NEA, A1/A2 style). Manuscript interpretation and trait-direction statements. Manuscript interpretation and risk comparison statements. VCF/BCF, variant normalization, coordinate harmonization. VCF/BCF and REF/ALT-based pipelines. Evolutionary/population-genetic annotation and directionality analyses. Evolutionary/population-genetic annotation and selection analyses. Frequency summaries and QC reporting. Frequency summaries, QC filters, and power interpretation. Experimental genetics, functional assays, and mechanism papers. Experimental genetics, clinical variant interpretation, and mechanism papers.
Can change with context? Yes, by coding convention. Yes, paired to effect-allele choice. Yes, by schema naming. Yes, by phenotype definition, ancestry, and model. Yes, same reasons as risk label. Tied to reference build/version choice. Tied to reference build/version choice. Depends on ancestral-state inference quality and outgroup data. Same inference dependence as ancestral-state labeling. Yes, depends on population and sample composition. Yes, depends on population and sample composition. Yes, depends on the chosen biological reference/background. Yes, depends on which wild-type baseline is defined.

Rule of thumb: first align effect/non-effect (or other) for sign consistency, then interpret risk/non-risk for phenotype direction, keep reference/alternative as assembly identity labels, treat ancestral/derived as evolutionary annotations, use major/minor only as dataset-specific frequency labels, and treat wild-type/mutant as context-specific functional labels.

Important caveats

  • The effect allele is not automatically the risk allele; risk depends on the sign and phenotype coding.
  • The alternative allele is not automatically minor, effect, or risk.
  • The reference allele is not necessarily the ancestral allele, and the alternative allele is not necessarily derived.
  • Major/minor status can flip across ancestries, cohorts, or after sample filtering.
  • Wild-type/mutant naming can be ambiguous in population-scale human datasets unless the baseline context is explicitly defined.
  • Risk direction can differ across studies because of trait encoding, covariates, ancestry composition, or sampling.

References